← Leaderboards
A Paula Monaghan-Nichols
University Of Pittsburgh At Pittsburgh
$4,509,943
Attributed
$7,797,407
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,797,407 · 4
By mechanism
R01$7,578,707 · 3
R25$218,700 · 1
Top collaborators
- Donald B Defranco11 shared
- Venkatesh Sampath5 shared
- Sandra Ann Murray1 shared
- Gonzalo E. Torres1 shared
- Michael J Zigmond1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Pat R Levitt$42,762,313
- Elizabeth M Powell$2,130,393
- Donald B Defranco$10,683,038
- Michael A Pulsipher$13,522,310
- George Christopher Gabriel$237,530
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsIn VitroBehaviorResponseAdultMolecularMass Spectrum AnalysisInfantPremature InfantGene ExpressionChildAffectGlucocorticoid ReceptorGlucocorticoidsDoseNeonatalBrainGene TargetingNeonateDexamethasonePharmaceutical PreparationsInnovationCell ProliferationSide Effect
Grant awards (21)
A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic Effects$550,615
R01 · FY2025 · HD
A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic Effects$579,211
R01 · FY2024 · HD
A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic Effects$600,982
R01 · FY2023 · HD
A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic Effects$593,864
R01 · FY2022 · HD
A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic Effects$606,797
R01 · FY2021 · HD
Selective Glucocorticoid Action in the Developing Brain$509,336
R01 · FY2021 · HD
Selective Glucocorticoid Action in the Developing Brain$449,936
R01 · FY2020 · HD
Selective Glucocorticoid Action in the Developing Brain$49,434
R01 · FY2020 · HD
Selective Glucocorticoid Action in the Developing Brain$449,936
R01 · FY2019 · HD
Selective Glucocorticoid Action in the Developing Brain$463,169
R01 · FY2018 · HD
Selective Glucocorticoid Action in the Developing Brain$416,441
R01 · FY2017 · HD
National Institute for Mentoring Early Minority Faculty in Neuroscience$218,700
R25 · FY2014 · NS
Molecular Genetic Analysis of Forebrain Development$271,721
R01 · FY2008 · MH · contact PI
Molecular Genetic Analysis of Forebrain Development$272,112
R01 · FY2007 · MH · contact PI
Molecular Genetic Analysis of Forebrain Development$280,629
R01 · FY2006 · MH · contact PI
Molecular Genetic Analysis of Forebrain Development$287,772
R01 · FY2005 · MH
Molecular Genetic Analysis of Forebrain Development$288,664
R01 · FY2004 · MH
MOLECULAR GENETIC ANALYSIS OF FOREBRAIN DEVELOPMENT$220,760
R01 · FY2003 · MH
MOLECULAR GENETIC ANALYSIS OF FOREBRAIN DEVELOPMENT$214,675
R01 · FY2002 · MH
MOLECULAR GENETIC ANALYSIS OF FOREBRAIN DEVELOPMENT$258,646
R01 · FY2001 · MH
MOLECULAR GENETIC ANALYSIS OF FOREBRAIN DEVELOPMENT$214,007
R01 · FY2000 · MH